Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.
C M Wei, … , V M Miller, J C Burnett Jr
C M Wei, … , V M Miller, J C Burnett Jr
Published October 1, 1993
Citation Information: J Clin Invest. 1993;92(4):2048-2052. https://doi.org/10.1172/JCI116800.
View: Text | PDF
Research Article Article has an altmetric score of 3

Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.

  • Text
  • PDF
Abstract

Authors

C M Wei, C H Kim, V M Miller, J C Burnett Jr

×

Total citations by year

Year: 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2011 2010 2009 2008 2007 2006 2005 2004 2002 2000 1996 1995 1994 1993 Total
Citations: 1 4 1 1 1 1 1 3 4 1 2 6 4 3 1 1 2 1 1 2 2 1 1 1 46
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (46)

Title and authors Publication Year
Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury
C Rico, K Konate, E Josse, J Nargeot, S Barrère-Lemaire, P Boisguérin
Frontiers in Cardiovascular Medicine 2022
Toward a New Paradigm for Targeted Natriuretic Peptide Enhancement in Heart Failure
O Gidlöf
Frontiers in physiology 2021
The Effects of Vasonatrin Peptide on Fat Graft Viability: An Experimental Study
F Irmak, M Sizmaz, SS Sirvan, S Karsidag, A Ozagari
Facial Plastic Surgery 2021
Atrial Natriuretic Peptide: Structure, Function, and Physiological Effects: A Narrative Review.
Rao S, Pena C, Shurmur S, Nugent K
Current cardiology reviews 2021
Vasonatrin peptide, a synthetic natriuretic peptide, attenuates myocardial injury and oxidative stress in isoprenaline-induced cardiomyocyte hypertrophy
P Chang, X Zhang, W Chen, J Zhang, J Wang, X Wang, J Yu, X Zhu
Peptides 2021
Natriuretic Peptides as the Basis of Peptide Drug Discovery for Cardiovascular Diseases
Y Lerner, W Hanout, SF Ben-Uliel, S Gani, MP Leshem, N Qvit
Current topics in medicinal chemistry 2020
C-type natriuretic peptide attenuates renal osteodystrophy through inhibition of FGF-23/MAPK signaling
DD Zhang, YF Wu, WX Chen, Y Xu, SY Liu, HH Luo, GM Jiang, Y Wu, P Hu
Experimental & molecular medicine 2019
Heart Failure: From Research to Clinical Practice
S Islam
2018
A New Chimeric Natriuretic Peptide, CNAAC, for the Treatment of Left Ventricular Dysfunction after Myocardial Infarction
SM Zhang, HL Zhao, XM Gu, J Li, N Feng, YM Wang, R Fan, WS Chen, JM Pei
Scientific Reports 2017
Innovative Therapeutics
LM Meems, JC Burnett
JACC: Basic to Translational Science 2016
Elevated Plasma B-Type Natriuretic Peptide Concentrations Directly Inhibit Circulating Neprilysin Activity in Heart Failure
N Vodovar, MF Séronde, S Laribi, E Gayat, J Lassus, JL Januzzi, R Boukef, S Nouira, P Manivet, JL Samuel, D Logeart, A Cohen-Solal, AM Richards, JM Launay, A Mebazaa
JACC: Heart Failure 2015
Cardiovascular and renal effect of CNAAC: An innovatively designed natriuretic peptide
S Zhang, X Geng, L Zhao, J Li, F Tian, N Feng, J Liu, L Cheng, J Pei
European Journal of Pharmacology 2015
Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms
Z Shi, F Fu, L Yu, W Xing, F Su, X Liang, R Tie, L Ji, M Zhu, J Yu, H Zhang
American journal of physiology. Heart and circulatory physiology 2015
The Effects of Vasonatrin Peptide on Random Pattern Skin Flap Survival:
SP Wang, ZY Lan, W Xia, X Zhao, GJ Ma, B Liu, BH Pan, SZ Guo
Annals of Plastic Surgery 2014
Natriuretic peptides in animal models of cardiovascular disease:
DS Burley, JS Bice, GF Baxter
Cardiovascular Endocrinology 2014
Vasonatrin peptide stimulates both of the natriuretic peptide receptors, NPRA and NPRB
YS Jiang, JY Lei, Y Chen, J Jin
Biochemical and Biophysical Research Communications 2014
Investigation of Cenderitide Controlled Release Platforms for Potential Local Treatment of Cardiovascular Pathology
XW Ng, Y Huang, KL Liu, FY Boey, SS Venkatraman
Journal of Pharmaceutical Sciences 2014
Vasonatrin peptide, a novel protector of dopaminergic neurons against the injuries induced by n-methyl-4-phenylpyridiniums
HK Zhao, BY Chen, R Chang, JB Wang, F Ni, L Yang, XC Dong, SH Sun, G Zhao, W Fang, QR Ma, XL Wang, J Yu
Peptides 2013
AC-NP: A Novel Chimeric Peptide with Natriuretic and Vasorelaxing Actions
BY Chen, JK Chen, MZ Zhu, DL Zhang, JS Sun, JM Pei, HS Feng, XX Zhu, J Jin, J Yu, C Zoccali
PloS one 2011
Vasonatrin peptide, a new regulator of adiponectin and interleukin-6 production in adipocytes
B-Y Chen, R Tie, P Qu, M-Z Zhu, X-X Zhu, J Jin, J Yu
Journal of Endocrinological Investigation 2011
Novel Natriuretic Peptides: New Compounds and New Approaches
MW Vogel, HH Chen
Current Heart Failure Reports 2010
C-type natriuretic peptide: Structural studies, fragment synthesis, and preliminary biological evaluation in human osteosarcoma cell lines
N Shaikh, L Russo, E Papaleo, P Giannoni, LD Gioia, F Nicotra, R Quarto, L Cipolla
Biopolymers 2010
Protective effects of vasonatrin peptide against hypobaric hypoxia-induced pulmonary hypertension in rats
J Yu, HS Feng, BY Chen, P Qu, LB Liu, JK Chen, R Tie, XJ Huang, YF Zhao, XX Zhu, MZ Zhu
Clinical and Experimental Pharmacology and Physiology 2010
Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis
BY Chen, P Qu, R Tie, MZ Zhu, XX Zhu, J Yu
Regulatory Peptides 2010
Natriuretic peptide drug leads from snake venom
S Vink, AH Jin, KJ Poth, GA Head, PF Alewood
Toxicon 2010
Vitamins & Hormones
KJ Hare, FK Knop
Vitamins & Hormones 2010
Designer natriuretic peptides
CY Lee, H Lieu, JC Burnett
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2009
ANP, BNP and CNP: Physiology and Pharmacology of the Cardiorenal Axis
CY Lee, JC Burnett
Textbook of Nephro-Endocrinology 2009
Structural Substrate Conditions Required for Neutral Endopeptidase-Mediated Natriuretic Peptide Degradation
K Pankow, A Schwiebs, M Becker, WE Siems, G Krause, T Walther
Journal of Molecular Biology 2009
Designer natriuretic peptides.
Lee CY, Lieu H, Burnett JC Jr
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2009
Insights into natriuretic peptides in heart failure: An update
J Korinek, G Boerrigter, SF Mohammed, JC Burnett
Current Heart Failure Reports 2008
Biology of the Natriuretic Peptides
A Martinez-Rumayor, AM Richards, JC Burnett, JL Januzzi
The American Journal of Cardiology 2008
Novel Bifunctional Natriuretic Peptides as Potential Therapeutics
DM Dickey, JC Burnett, LR Potter
The Journal of biological chemistry 2008
Natriuretic peptides and therapeutic applications
CY Lee, JC Burnett
Heart Failure Reviews 2007
Natriuretic peptides as therapeutic targets
S Mukaddam-Daher
Expert Opinion on Therapeutic Targets 2006
Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells
SY Lu, DS Wang, MZ Zhu, QH Zhang, YZ Hu, JM Pei
Life Sciences 2005
Receptor subtypes for vasonatrin peptide in renal glomeruli and arteries
GE Woodard, X Li, JA Rosado
Regulatory Peptides 2005
Gene transfer of a novel vasoactive natriuretic peptide stimulates cGMP and lowers blood pressure in mice
S Pan, R Gulati, CS Mueske, TA Witt, A Lerman, JC Burnett, RD Simari
American journal of physiology. Heart and circulatory physiology 2004
Differential responses of newborn pulmonary arteries and veins to atrial and C-type natriuretic peptides
JF Tolsa, Y Gao, FC Sander, AC Souici, A Moessinger, JU Raj
American journal of physiology. Heart and circulatory physiology 2002
Mechanism of Relaxations to Dendroaspis Natriuretic Peptide in Canine Coronary Arteries
E Collins, MP Bracamonte, JC Burnett, VM Miller
Journal of Cardiovascular Pharmacology 2000
Practical implications of current natriuretic peptide research
GA Sagnella
Journal of Renin-Angiotensin-Aldosterone System 2000
C-Type Natriuretic Peptide
CS Barr, P Rhodes, AD Struthers
Peptides 1996
Neuroendocrine changes in chronic cardiac failure
D P Nicholls, G N Onuoha, G McDowell, J S Elborn, M S Riley, A M Nugent, I C Steele, C Shaw, K D Buchanan
Basic Research in Cardiology 1996
The natriuretic peptide family
G McDOWELL, C Shaw, KD Buchanan, DP Nicholls
European Journal of Clinical Investigation 1995
Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro
CM Wei, CH Kim, AA Khraibi, VM Miller, JC Burnett
Hypertension 1994
Designer natriuretic peptides
DG Gardner
Journal of Clinical Investigation 1993

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 8 patents
9 readers on Mendeley
See more details